| Bridget E Heckler, CNM | |
|
1140 S Knoxville Ave Ste B, Saint Marys, OH 45885-2609 | |
| (419) 394-7314 | |
| (419) 394-7313 |
| Full Name | Bridget E Heckler |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 27 Years |
| Location | 1140 S Knoxville Ave Ste B, Saint Marys, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497780233 | NPI | - | NPPES |
| 9934723 | Other | OH | MEDICARE GROUP PTAN |
| 1447288717 | Other | OH | GROUP NPI |
| H295760 | Other | OH | MEDICARE INDIVIDUAL PTAN |
| 2070459 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | COA-00663-NM (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Grand Lake Health System | Saint marys, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jtdm Family Practice Llc | 2163415837 | 39 |
News Archive
Taking medical 'selfies' and sharing them with a doctor empowers and reassures healthcare consumers, and can improve doctor-patient relationships, a two-part study led by Queensland University of Technology in Brisbane, Australia has found.
PTC Therapeutics, Inc. (PTC) today announced it is expanding the development of ataluren, an investigational new drug, to a third indication with the initiation of a Phase 2a clinical trial in nonsense mutation hemophilia A (nmHA) and hemophilia B (nmHB).
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the expansion of their research, development and license agreement for the discovery of novel kinase inhibitors in the field of oncology. This expanded agreement establishes a third therapeutic target, with an option for a fourth, in the field of oncology, and it includes a two-year extension based on the application of the proprietary ArQule Kinase Inhibitor Platform (AKIP™) technology.
Pfizer Inc. announced today that the United States District Court for the District of Delaware upheld its composition of matter patent and pain and seizure use patents covering LYRICA (pregabalin) capsules CV. With this decision, Pfizer will exclusively provide pregabalin as LYRICA to patients through December 30, 2018 in the U.S., pending generic company appeal and further litigation.
Yale Cancer Center has launched the Yale Center for Immuno-Oncology. The new center will build on YCC's international leadership in immunobiology, cancer immunology, and development of novel cancer immunotherapies. It is a partnership between YCC and the department of Immunobiology at Yale University.
› Verified 5 days ago
| Entity Name | Jtdm Family Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184652539 PECOS PAC ID: 2163415837 Enrollment ID: O20040407000863 |
News Archive
Taking medical 'selfies' and sharing them with a doctor empowers and reassures healthcare consumers, and can improve doctor-patient relationships, a two-part study led by Queensland University of Technology in Brisbane, Australia has found.
PTC Therapeutics, Inc. (PTC) today announced it is expanding the development of ataluren, an investigational new drug, to a third indication with the initiation of a Phase 2a clinical trial in nonsense mutation hemophilia A (nmHA) and hemophilia B (nmHB).
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the expansion of their research, development and license agreement for the discovery of novel kinase inhibitors in the field of oncology. This expanded agreement establishes a third therapeutic target, with an option for a fourth, in the field of oncology, and it includes a two-year extension based on the application of the proprietary ArQule Kinase Inhibitor Platform (AKIP™) technology.
Pfizer Inc. announced today that the United States District Court for the District of Delaware upheld its composition of matter patent and pain and seizure use patents covering LYRICA (pregabalin) capsules CV. With this decision, Pfizer will exclusively provide pregabalin as LYRICA to patients through December 30, 2018 in the U.S., pending generic company appeal and further litigation.
Yale Cancer Center has launched the Yale Center for Immuno-Oncology. The new center will build on YCC's international leadership in immunobiology, cancer immunology, and development of novel cancer immunotherapies. It is a partnership between YCC and the department of Immunobiology at Yale University.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bridget E Heckler, CNM 200 Saint Clair Ave, Saint Marys, OH 45885-2400 Ph: (419) 300-1129 | Bridget E Heckler, CNM 1140 S Knoxville Ave Ste B, Saint Marys, OH 45885-2609 Ph: (419) 394-7314 |
News Archive
Taking medical 'selfies' and sharing them with a doctor empowers and reassures healthcare consumers, and can improve doctor-patient relationships, a two-part study led by Queensland University of Technology in Brisbane, Australia has found.
PTC Therapeutics, Inc. (PTC) today announced it is expanding the development of ataluren, an investigational new drug, to a third indication with the initiation of a Phase 2a clinical trial in nonsense mutation hemophilia A (nmHA) and hemophilia B (nmHB).
ArQule, Inc. and Daiichi Sankyo Co., Ltd. today announced the expansion of their research, development and license agreement for the discovery of novel kinase inhibitors in the field of oncology. This expanded agreement establishes a third therapeutic target, with an option for a fourth, in the field of oncology, and it includes a two-year extension based on the application of the proprietary ArQule Kinase Inhibitor Platform (AKIP™) technology.
Pfizer Inc. announced today that the United States District Court for the District of Delaware upheld its composition of matter patent and pain and seizure use patents covering LYRICA (pregabalin) capsules CV. With this decision, Pfizer will exclusively provide pregabalin as LYRICA to patients through December 30, 2018 in the U.S., pending generic company appeal and further litigation.
Yale Cancer Center has launched the Yale Center for Immuno-Oncology. The new center will build on YCC's international leadership in immunobiology, cancer immunology, and development of novel cancer immunotherapies. It is a partnership between YCC and the department of Immunobiology at Yale University.
› Verified 5 days ago
Whitney Nicole Clark, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1140 S Knoxville Ave Ste B, Saint Marys, OH 45885 Phone: 419-394-7314 Fax: 419-394-7313 | |
Brittani Skelton, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1140 S Knoxville Ave Ste B, Saint Marys, OH 45885 Phone: 419-394-7314 |